ARTICLE | Company News
Neurocrine other research news
November 5, 2001 8:00 AM UTC
NBIX received a 2-year $1 million Phase II SBIR grant from the National Institute of Child Health and Human Development to develop small molecule GnRH receptor antagonists to treat uterine fibroids, e...